The role of the LAA for AF and stroke: fact or fiction

19 March 2018 (16:48 - 17:06)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Thorsten Lewalter

Hospital Munich South, Munich (Germany)

5 More presentations in this session

Presentation thumbnail

This session is supported by Abbott and Boston Scientific in the form of an educational grant. The scientific programme has not been influenced in any way by these sponsors.

Presentation thumbnail

Stroke prevention or bleeding: how to weigh the results of clinical trials

Professor L. Boersma (Nieuwegein, NL)

Presentation thumbnail

LAA closure concomitant to AF ablation - The surgical perspective

Associate Professor S. Salzberg (Zurich, CH)

Presentation thumbnail

LAA closure concomitant to AF ablation - The EP perspective

Professor C. Tondo (Milano, IT)

Presentation thumbnail

New strategies for anticoagulation therapy after LAA closure

Professor M. Glikson (Jerusalem, IL)

Access the full session

Session thumbnail

Novel insights of LAA treatment for atrial fibrillation and stroke prevention

The Event

EHRA 2018

19 March 2018 16:48 CET

You may be interested in

Congress Presentation

Left atrial appendage closure in atrial fibrillation: gaps in knowledge

1 September 2025

Congress Session

EHRA honorary lectures

31 March 2025

Congress Presentation

Associations between stroke risk factors and left atrial low-voltage areas in patients with atrial fibrillation undergoing catheter ablation from the REAL-AF registry

7 April 2024

Congress Presentation

Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.

26 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources